AN ACT CONCERNING COST TRANSPARENCY IN LEGEND DRUG ADVERTISEMENTS.
Connecticut bill mandates prescription drug ads disclose retail prices or link to pricing information, increasing consumer awareness of medication costs before doctor consultations.
Connecticut bill mandates prescription drug ads disclose retail prices or link to pricing information, increasing consumer awareness of medication costs before doctor consultations.
SB 436 requires pharmaceutical companies to disclose pricing information in direct-to-consumer advertisements for prescription drugs ("legend drugs"). The bill mandates that ads include the drug's retail price or, if unavailable, direct consumers to easily accessible pricing information. This applies to advertisements in all media formats.
Prescription drug costs remain a major driver of healthcare expenses and financial hardship for patients. Currently, pharmaceutical ads often highlight benefits without mentioning cost, making it difficult for consumers to understand affordability before discussing medications with doctors. Price transparency in ads could enable more informed healthcare decisions and prompt earlier conversations about generic alternatives or treatment costs.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.